Memorial Sloan-Kettering Cancer Center (MSKCC) - New York — New York, New York

Memorial Sloan-Kettering Cancer Center (MSKCC) - New York is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Memorial Sloan-Kettering Cancer Center (MSKCC) - New York has participated in 10 clinical trials with 8 currently active.

Therapeutic areas: Locally Advanced Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma.

Sponsors: EMD Serono Research & Development Institute, Inc., Eli Lilly and Company, Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memorial Sloan-Kettering Cancer Center (MSKCC) - New York?

Memorial Sloan-Kettering Cancer Center (MSKCC) - New York has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memorial Sloan-Kettering Cancer Center (MSKCC) - New York conducted?

Memorial Sloan-Kettering Cancer Center (MSKCC) - New York has 10 clinical trials on record, with 8 currently active. Their work covers Locally Advanced Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma.

Is Memorial Sloan-Kettering Cancer Center (MSKCC) - New York accredited by Crixeo Health?

Yes — Memorial Sloan-Kettering Cancer Center (MSKCC) - New York holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Memorial Sloan-Kettering Cancer Center (MSKCC) - New York?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.